By cutting down on unnecessary in-person appointments in post-surgical pathways, Isla is making a significant impact, saving an average of 60 miles of travel per patient. This not only significantly reduces carbon emissions, aligning with the NHS’s net-zero ambitions, but also ensures inclusive, high-quality care. Many patients face travel challenges due to work commitments or childcare responsibilities. A new poll of 2,000 adults in England, found that the number of people who avoided an NHS appointment due to the cost of travel rose from 6% in October 2022 to 11% in December 2022, with fears that the continued Cost of Living crisis will mean many more “Did Not Attends” this year. Enabling remote postoperative care ensures that patients can still receive treatment without having the cost and inconvenience of travel.
Surgical Site Infection (SSI) exerts a £700 million annual toll on the NHS, causing avoidable readmissions and extended bed occupancy. In the UK, SSI accounts for up to 1 in 7 hospital-acquired infections. Across several NHS Trusts, Isla is paving the way to reduce SSI occurrences while enhancing patient convenience and overall clinical efficiency.
Isla is partnered with over 30 NHS Trusts, where co-development ensures the platform aligns seamlessly with surgical pathways and clinician needs. The platform allows clinicians to remotely request patient images and structured questionnaires, creating a clear record of the patient’s progress. Where clinically appropriate, automated workflows facilitate the continuous flow of patient data, where patient submissions can be requested and received with no additional administrative burden.
Isla’s impact can already be seen in active Trusts:
NHS Trusts deploy Isla in three pivotal ways:
Baseline Imaging: Pre and post-operative baseline images are captured, allowing healing measurement against the patient’s pre-surgery state.
Safe Early Discharge: Isla facilitates safe early discharge, accompanied by precise and secure recovery tracking through updated videos, images, voice notes, and clinical questionnaires.
Continuous Data Collection: Patients provide vital information through automated requests, optimising efficiency and enabling recovery at home.
Isla aids the collection of images and wound assessments in real time, allowing for early detection of infection and precise tracking of wound progress. Patients also receive automated follow-up requests for wound photos.
Impact: During the study 8 infections were found using the Isla pathway, allowing them to be dealt with more quickly than through traditional pathways.
In a study at Liverpool Heart and Chest Hospital 8 out the 9 SSI infections in the subject group were identified using Isla.
The average cost of a readmission in Cardiac Surgery is a staggering £20,385. Moreover, Isla significantly reduces wound review time, with an average of just 8 minutes—a remarkable 60% improvement over prior methods.
At NHS Lothian, the use of Isla within the Tracking Wound Infection with Smartphone Technology (TWIST) tool accelerates the diagnosis of wound infections and reduces healthcare service utilisation.
Impact: In a randomised controlled trial of 500 abdominal surgery patients, wound infections are diagnosed earlier. Fewer healthcare service visits are needed, and patients report a smoother, faster, and higher-quality care experience.
Isla streamlines C-section care similar to the cardiac pathway, with real-time photo submissions available to relevant clinicians across Acute and Community settings, reducing the need for people who have just given birth to have to travel to hospitals and clinics for appointments.
In Breast Surgery, Isla reduces reliance on Medical Photography. Clinicians securely capture pre-op and post-op baseline images using their smartphones, fostering efficient postoperative care. Patients can also send secure photos from home for comparison.
Reducing SSI instances aligns with NHS goals regarding antibiotic stewardship, mitigating the need for more antibiotics and, in turn, lowering antimicrobial resistance (AMR). The World Health Organization has identified AMR as one of the top 10 global public health threats. Fewer readmissions and surgeries also reduce the consumption of single-use plastics and chemicals that flow into water systems.
Isla stands ready to collaborate with Trusts nationwide, enhancing clinical efficiency and patient outcomes post-surgery. If you’re interested in reducing readmissions, streamlining workflows, and improving patient experiences, please get in touch with Isla.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
See health differently
© 2024 ISLACARE LTD a company registered in England & Wales company registration number 12108076
Find out more